title: C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age.
abstract: Age-dependent poliomyelitis is a paralytic disease of C58 and AKR mice caused by cytocidal infection of anterior horn neurons with neuropathogenic strains of lactate dehydrogenase-elevating virus (LDV). The motor neurons are rendered LDV-permissive via an unknown mechanism through the expression of ecotropic murine leukemia virus (MuLV) in central nervous system (CNS) glial cells. Only old mice develop paralytic disease after LDV infection, but mice 5-6 months old or older can be rendered susceptible by suppression of anti-LDV immune responses by a single treatment with cyclophosphamide or X-irradiation before LDV infection. Younger mice appeared to be resistant in spite of this immunosuppresive treatment. The present results confirm that mice as young as 1 month of age possess CNS cells expressing ecotropic MuLV and show that these mice are susceptible to paralytic LDV infection provided their anti-LDV immune responses are blocked for an extended period of time by repeated cyclophosphamide treatments or by a genetic defect. Furthermore, old mice become naturally susceptible to paralytic LDV infection because of an impaired ability to mount a motor neuron protective anti-LDV immune response.
authors.affiliation: Department of Microbiology, University of Minnesota Medical School, Minneapolis 55455-0312, USA.
authors.forename: G W
authors.initials: GW
authors.lastname: Anderson
authors.forename: C
authors.initials: C
authors.lastname: Even
authors.forename: R R
authors.initials: RR
authors.lastname: Rowland
authors.forename: G A
authors.initials: GA
authors.lastname: Palmer
authors.forename: J T
authors.initials: JT
authors.lastname: Harty
authors.forename: P G
authors.initials: PG
authors.lastname: Plagemann
mesh_terms: D000375:Aging / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D018174:Arterivirus Infections / Q000276:immunology*; D015152:Blotting, Northern; D016572:Cyclosporine / Q000494:pharmacology; D005260:Female; D007107:Immune System / Q000187:drug effects / Q000821:virology; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007772:Lactate dehydrogenase-elevating virus / Q000276:immunology*; D009052:Leukemia Virus, Murine / Q000235:genetics; D008297:Male; D051379:Mice; D008806:Mice, Inbred AKR; D008822:Mice, Transgenic; D016472:Motor Neuron Disease / Q000235:genetics / Q000276:immunology / Q000821:virology*; D011051:Poliomyelitis / Q000276:immunology / Q000821:virology; D012367:RNA, Viral / Q000032:analysis; D013116:Spinal Cord / Q000821:virology
chemical_list: D000914:Antibodies, Viral; D007166:Immunosuppressive Agents; D012367:RNA, Viral; D016572:Cyclosporine